Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017
November 16, 2017
Guardant Health Expands Support for the Development of the GuardantOMNI™ Assay Through New Agreement with Bristol-Myers Squibb
November 15, 2017
New Research Reveals Molecular Heterogeneity of Metastatic Gastroesophageal Cancer
November 6, 2017
Guardant Health Database Reveals Potential of Targeted Therapy Combinations to Treat Advanced Lung Cancer
October 2, 2017
Study Demonstrates Potential for the Guardant360 Assay® to Predict Which Patients Will Benefit from Immunotherapy
September 26, 2017
Guardant Health Receives Investigational Device Exemption Approval from the FDA to Support Merck KGaA, Darmstadt, Germany Tepotinib Study